Singapore vs South Africa: Number of clinical trials
Singapore
57
in 2024
South Africa
54
in 2024
Singapore rank
35th
South Africa rank
37th
Number of clinical trials over time
- Singapore
- South Africa
How they compare
Singapore currently reports 57 against 54 in South Africa, a difference of 3.
That makes Singapore's figure about 1.1 times South Africa's.
The two have swapped places 3 times across 24 shared years of data; in 2001 it was South Africa ahead.
Singapore ranks 35th and South Africa ranks 37th of 153 countries.
Singapore has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Singapore | South Africa | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 11 | 9.89 | 1.11 | Singapore |
| 2010s | 53.2 | 38.7 | 14.5 | Singapore |
| 2020s | 72 | 48.6 | 23.4 | Singapore |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of clinical trials, Singapore or South Africa?
- Singapore, at 57 against 54 in South Africa as of 2024.
- What is the difference in number of clinical trials between Singapore and South Africa?
- 3, with Singapore ahead.
- How many years of comparable data are there for Singapore and South Africa?
- 24 years are reported by both, from 2001 to 2024.
- How do Singapore and South Africa rank globally for number of clinical trials?
- Singapore ranks 35th and South Africa ranks 37th of 153 countries.
- Where does this data come from?
- Our World in Data, published as Number of clinical trials. Statizoid refreshes it automatically from the source and publishes the full history for both places.